DPP-IV Inhibitors Market to Reach US$18.8 Bn by 2033 at 6.0% CAGR | Persistence Market Research
The DPP-IV inhibitors market is growing steadily, driven by rising diabetes prevalence, favorable safety profiles, and expanding access to oral therapies. LONDON, UNITED KINGDOM, March 12, 2026 /EINPresswire.com/ -- The global DPP-IV inhibitors market …